6 High-Volume Stocks With Relative Strength
Cubist Pharmaceuticals
Cubist Pharmaceuticals (CBST) is a biopharmaceutical company focused on the research, development and commercialization of therapies to treat serious medical conditions in acutely ill patients who are hospitalized or are being treated in other acute care settings. This stock is trading up 1.4% at $41.20 in recent trading.
Today's Volume: 859,000
Average Volume: 800,610 Volume % Change: 88% >>5 Biotech Stocks Under $10 Set to Soar Shares of CBST are moving modestly higher today after the company beat Wall Street expectations as sales for its lead drug Cubicin soared. Total revenue registered a 30% rise to $231 million, and Cubicin sales rose 20% to $212 million. From a technical perspective, CBST is moving modestly higher here with above average volume, after the stock briefly traded below both its 50-day and 200-day moving averages. This move is now pushing CBST within range of triggering a near-term breakout trade. That trade will trigger once CBST takes out some near-term overhead resistance at $41.85 with high volume. Traders should now look for long-biased trades once CBST sustains a move or close over $41.85 with volume that's near or above 800,610 shares. If we get that action soon, then CBST will have a great chance of re-testing and possibly taking out its next major overhead resistance levels at $43 to $44.95.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
